Dr. Mason on the significant results from the PROTECT study in prostate cancer

Malcom Mason, MD, Cancer Research Wales Professor of Clinical Oncology at Cardiff University, discusses the significant results of the PROTECT study for patients with prostate cancer. The purpose of the PROTECT study was to directly test 3 major modalities of treatment for localised prostate cancer, which included external beam radiotherapy, radical prostatectomy, or active monitoring in healthy patients who underwent prostate specific antigen (PSA) screening.